Show notes
In today’s episode, Dr. Carrie Jones is joined by Craig Strasnick, President and CEO of Commonwealth Diagnostics International. They discuss small intestinal bacterial overgrowth, known as SIBO, and intestinal methanogen overgrowth, known as IMO and how the diagnostic side of GI disturbances provides important data that helps guide research and the development of therapies to help patients find relief.
As the President and CEO of CDI, Craig collaborates with international academics and industry leaders to improve current gastroenterological practices. He graduated from Northeastern University with a degree in Business Administration and founded CDI in 2015 after securing the acquisition of Commonwealth Laboratories. In 2021, Forbes named Craig Strasnick and Commonwealth Diagnostics International to the Forbes Next 1000. Craig is also a Board Member of Functional Gut Diagnostics, GI Logic, and My Total Health.
Learn more about Craig Strasnick:
As the President and CEO of CDI, Craig collaborates with international academics and industry leaders to improve current gastroenterological practices. He graduated from Northeastern University with a degree in Business Administration and founded CDI in 2015 after securing the acquisition of Commonwealth Laboratories. In 2021, Forbes named Craig Strasnick and Commonwealth Diagnostics International to the Forbes Next 1000. Craig is also a Board Member of Functional Gut Diagnostics, GI Logic, and My Total Health.
Learn more about Craig Strasnick:
Rupa Health Details:
- Rupa Health's Website
- Rupa Health on LinkedIn
- Rupa Health on Facebook
- Rupa Health on Instagram
- Rupa Health on Tik Tok
- Rupa Health on YouTube
- Rupa Health Reference Guide
- Dr. Carrie Jones on LinkedIn
- Dr. Carrie Jones on Instagram
- Dr. Carrie Jones on TikTok
If you enjoyed this episode then please either:
- Follow, rate, and review on Apple Podcasts
- Follow on Spotify
